CognivAiD Real-World Evidence Clinical Registry (CONNECT Registry)

Launched by MOLEAC PTE LTD. · Jan 18, 2024

Keywords

ClinConnect Summary

The CONNECT Registry is a study that aims to gather information about the use of a medication called CognivAiD, which is prescribed for people experiencing memory problems, dementia, or vascular issues. This research is designed to see how well CognivAiD works and is used in everyday life, outside of controlled clinical trials. Researchers will look at different ways the medication is used, such as when patients switch treatments or use it along with other medications.

To participate in this study, individuals must be of legal age and either currently taking CognivAiD or set to receive a prescription for it. It's important that they agree to be part of the registry and provide consent for their information to be collected and analyzed. Participants can expect to be part of an ongoing effort to understand how CognivAiD is helping people in real-world settings. The study is currently recruiting participants of all genders and is open to a wide age range, from 65 to 99 years old.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female
• • Legal age as per country requirement
• • Already taking or having to receive a prescription for CognivAiD (decision must have been made before consideration to participate in the registry)
• • Agrees to be included in the registry, provides written consent inclusion criteria
• • Male or female
• • Legal age as per country requirement
• • Already taking or having to receive a prescription for CognivAiD (decision must have been made before consideration to participate in the registry)
• • Agrees to be included in the registry, provides written consent, and allows retrieval and analysis of data by local requirements.

Trial Officials